{"contentid": 488429, "importid": NaN, "name": "BMS to build new cell therapy manufacturing site in Europe", "introduction": "US pharma major Bristol Myers Squibb is expanding its global manufacturing footprint by investing in a new cell therapy manufacturing site in the Netherlands.", "content": "<p>US pharma major Bristol Myers Squibb (NYSE: BMS) is expanding its global manufacturing footprint by investing in a new cell therapy manufacturing site in the Netherlands.</p>\n<p>The site will be based in the Leiden Bio Science Park, the region&rsquo;s growing life sciences hub, which is conveniently located near transportation to ship patient cells. Construction is slated to begin later this year.</p>\n<p>The facility &ndash; which will be BMS&rsquo; fifth state-of-the-art site globally and first in Europe &ndash; will have capabilities for multi-product cell therapy manufacturing, including potentially liso-cel and ide-cel (pending regulatory approval). The facility will also leverage innovative technology, the latest manufacturing equipment and advanced digital systems to deliver critical cell therapies to patients in Europe.</p>\n<p>&ldquo;A key element of BMS&rsquo; commitment to cell therapy is our continuous investment in advanced manufacturing capabilities, from the expansion of our global network and capacity to treat patients to reduced turn-around time and optimized costs,&rdquo; said Ann Lee, senior vice president, Cell Therapy Development &amp; Operations, Bristol Myers Squibb.</p>\n<p>&ldquo;We continue to grow our presence in Europe and the Netherlands, which offers an innovative life sciences hub and world class industry talent, and we look forward to hiring several hundred talented people over the coming years to join our global team and participate in our cell therapy journey,&rdquo; she noted.&nbsp;&nbsp;</p>\n<h2><strong>Hiring hundreds of employees</strong></h2>\n<p>BMS plans to hire several hundred employees to join the global cell therapy team, in addition to the construction hiring that will add to the local economy.</p>\n<p>The European facility will be commercially focused with capabilities for multi-product cell therapy manufacturing and the ability to scale up capacity. It will leverage innovative technologies, the latest manufacturing equipment and advanced digital systems to deliver these critical cell therapies to patients.</p>\n<p>Planning for site design and development is underway, with construction slated to begin later this year.</p>", "date": "2021-04-22 14:22:00", "meta_title": "BMS to build new cell therapy manufacturing site in Europe", "meta_keywords": "Bristol Myers Squibb, Manufacturing, Facility, Investment, Leiden, Cell therapies", "meta_description": "BMS to build new cell therapy manufacturing site in Europe", "meta_robots": NaN, "meta_display_in_sitemap": 1, "canonical_url": NaN, "status": 3, "access_status": 0, "ignore_flexible_sampling": 0, "display_start_date": "0000-00-00 00:00:00", "display_end_date": "0000-00-00 00:00:00", "display_in_search": 1, "created": "2021-04-22 14:21:05", "updated": "2021-04-22 14:27:53", "access": NaN, "url": "https://www.thepharmaletter.com/article/bms-to-build-new-cell-therapy-manufacturing-site-in-europe", "description": NaN, "twitter_term": NaN, "twitter_widgetid": NaN, "key_facts": NaN, "news_snippet": NaN, "image1id": "bristol_myers_large-1.jpg", "image2id": "bristol_myers_small-1.jpg", "restrict_print": 0, "restrict_print_for_logged_out": 0, "box1_header": NaN, "box1_title": NaN, "box1_image1id": 0, "box1_url": NaN, "box1_introduction": NaN, "box1_position": 0, "tags": NaN, "sector_tag": "Biotechnology", "therapy area_tag": "Cell and Gene Therapy", "topic_tag": "Management, Production", "geography_tag": "Netherlands, USA", "company_tag": "Bristol-Myers Squibb", "drug_tag": NaN, "market index_tag": NaN, "theme_tag": NaN, "industry sector_tag": NaN, "medical condition_tag": NaN, "industry term_tag": NaN, "organization_tag": NaN, "person_tag": NaN, "position_tag": NaN, "medical treatment_tag": NaN, "facility_tag": NaN, "technology_tag": NaN, "journalist_tag": NaN, "published medium_tag": NaN, "political event_tag": NaN, "anniversary_tag": NaN, "sports event_tag": NaN, "movie_tag": NaN, "fax number_tag": NaN, "currency pair_tag": NaN, "sports league_tag": NaN, "date_tag": NaN, "music group_tag": NaN, "phone number_tag": NaN, "t v show_tag": NaN, "t v station_tag": NaN, "entertainment award event_tag": NaN, "industry_tag": NaN, "pharmaceutical drug_tag": NaN, "topmost public parent company_tag": NaN, "content_type_name": "Article", "pubDate": "2021-04-22 14:22:00"}